Literature DB >> 11315244

Physical activity and risk factors for hip fractures in Thai women.

N Boonyaratavej1, P Suriyawongpaisal, A Takkinsatien, S Wanvarie, R Rajatanavin, P Apiyasawat.   

Abstract

Hip fractures are among the most important causes of ill health and death among elderly people. Several potentially modifiable risk factors have been reported. Most claimed physical activity as a promising, inexpensive preventive measure for hip fracture. However, knowledge about risk factors for hip fracture in Asian populations is very limited. We therefore conducted a case-control study to assess the relationships between physical activity and risk of hip fractures in Thai women. From 14 hospitals in Thailand, 229 cases with a radiologically confirmed first hip fracture were enrolled. Two hundred and twenty-four controls were randomly recruited from the same neighborhood and were matched to the cases by age within a 5 year range. Information on physical activity as well as other potential confounders was obtained through personal interviews. Multivariate logistic regression revealed that past physical activity was protective in both very active and active women (OR = 0.67, 95% CI = 0.40-1.12 for moderately active women and OR = 0.20, 95% CI = 0.10-0.38 for very active women; p value for trend < 0.01). Recent physical activity reduced the risk to about two-thirds (OR = 0.33, 95% CI = 0.19-0.60 and OR = 0.35, 95% CI = 0.18-0.69 for moderately and very active women respectively). In addition, breastfeeding was identified to be a protective factor (OR = 0.87, 95% CI = 0.80-0.94). In contrast, the following risk factors were identified: current use of antihistamine (OR = 13.96, 95% CI = 1.38-141.13) or traditional medicine (OR = 7.66, 95% CI = 2.71-21.63), underlying cerebrovascular diseases (OR = 6.53, 95% CI = 2.10-20.34), history of fracture (OR = 4.04, 95% CI = 1.26-12.99), parental Chinese racial background (OR = 2.52, 95% CI = 1.49-4.23), alcohol consumption (OR = 2.30, 95% CI = 1.04-5.09).

Entities:  

Mesh:

Year:  2001        PMID: 11315244     DOI: 10.1007/s001980170136

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  7 in total

1.  Driving ability after acute and sub-chronic administration of levocetirizine and diphenhydramine: a randomized, double-blind, placebo-controlled trial.

Authors:  Joris C Verster; A Marit de Weert; Saskia I R Bijtjes; Mounir Aarab; Armand W A A van Oosterwijck; Erik J E Eijken; Marinus N Verbaten; Edmund R Volkerts
Journal:  Psychopharmacology (Berl)       Date:  2003-04-30       Impact factor: 4.530

2.  Effects of physical activity and dietary calcium intake on bone mineral density and osteoporosis risk in a rural Thai population.

Authors:  C Pongchaiyakul; T V Nguyen; V Kosulwat; N Rojroongwasinkul; S Charoenkiatkul; J A Eisman; R Rajatanavin
Journal:  Osteoporos Int       Date:  2004-06-03       Impact factor: 4.507

3.  Childhood and adult mortality from unintentional falls in India.

Authors:  Jagnoor Jagnoor; Wilson Suraweera; Lisa Keay; Rebecca Q Ivers; J S Thakur; Gopalkrishna Gururaj; Prabhat Jha
Journal:  Bull World Health Organ       Date:  2011-08-03       Impact factor: 9.408

4.  Influence of reproductive factors on hip fracture risk in Chinese women.

Authors:  Dezheng Huo; Diane S Lauderdale; Liming Li
Journal:  Osteoporos Int       Date:  2003-07-19       Impact factor: 4.507

5.  Muscle forces or gravity: what predominates mechanical loading on bone?

Authors:  Wendy M Kohrt; Daniel W Barry; Robert S Schwartz
Journal:  Med Sci Sports Exerc       Date:  2009-11       Impact factor: 5.411

6.  The influence of pregnancy and lactation on maternal bone health: a systematic review.

Authors:  Pooneh Salari; Mohammad Abdollahi
Journal:  J Family Reprod Health       Date:  2014-12

7.  Physical activity and sedentary behaviour research in Thailand: a systematic scoping review.

Authors:  Nucharapon Liangruenrom; Kanyapat Suttikasem; Melinda Craike; Jason A Bennie; Stuart J H Biddle; Zeljko Pedisic
Journal:  BMC Public Health       Date:  2018-06-14       Impact factor: 3.295

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.